Hospital-Acquired Infection Control Market Expected to Reach $25.00 Billion by 2030—Allied Market Research

According to a new report published by Allied Market Research, titled, “Hospital-Acquired Infection Control Market by Product & Service, Infection Type, and End User: Global Opportunity Analysis and Industry Forecast, 2022–2030," the global hospital-acquired infection control market was valued at $19,958 million in 2020, and is projected to reach $25,006 million by 2030, registering a CAGR of 4.6% from 2022 to 2030.

Infections are majorly transmitted through hands, inhalation, ingestion, and equipment. Different types of infections include hospital-acquired infections, common childhood infections, stomach & intestinal infections, skin infections, lung & respiratory infections, eye infections, ear infections, and sexually transmitted infections (STDs). Hands of patients can carry microbes to other body sites, equipment, and healthcare staff. Therefore, hospital-acquired infection control is concerned with preventing and controlling healthcare-associated infections and sterilization technique is a major component of invasive surgical procedure.

Increase in number of surgical procedures, rise in incidence of hospital-acquired infection, technological advancements in sterilization & disinfection technologies, surge in geriatric population, and increase in government & nongovernment initiatives to spread awareness concerning need for disinfection & proper hygiene are the major factors that boost the growth of the global hospital-acquired infection control market.

In addition, reintroduction of ethylene oxide sterilization, incidence of chronic diseases, rise in outsourcing of sterilization services among hospitals, pharmaceutical & medical device companies, surge in use of e-beam sterilization, and increase in adoption of single-use medical nonwovens & devices are other factors that augment the growth of the market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the market. On the contrary, rise in adoption of single-use medical nonwovens and devices is expected to offer potential growth opportunities for the market during the forecast period.

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. Hospital-acquired infection control market is positively impacted by the COVID-19 pandemic. Nonwoven and gloves manufacturers are expanding their production capacity to manufacture their products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases and surge in need for healthcare workers are expected to drive the demand for nonwoven & gloves products and disposable hospital supplies. In addition, due to the rapid spread of the virus, healthcare professionals associated with collection of specimens require proper protection, including gloves, coveralls, masks, and caps to prevent themselves from getting infected. Moreover, protective barrier products form a crucial part of the personal protective equipment (PPE) worn by healthcare professionals.

Furthermore, increase in use of gloves and medical nonwoven products such as face masks, gowns, and shoe cover in hospitals is anticipated show positive impact on the market. Therefore, alarming rise in prevalence of contagious diseases and the outbreak of the COVID-19 pandemic are anticipated to fuel the growth of the hospital-acquired infection control market during the forecast period.

The hospital-acquired infection control market is segmented into product & service, infection type, end user, and region. 

On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Presently, the protective barriers segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to rise in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to surge in COVID-19 cases, surge in number of surgeries, and increase in public awareness toward personal hygiene.

According to end user, the market is classified into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is anticipated to depict significant growth during the forecast period, due to rise in prevalence of hospital-acquired infections, surge in geriatric population (as this population is more susceptible to various chronic diseases), rise in volume of surgical procedures performed in hospitals, and surge in number of hospitals & clinics worldwide boost the market growth.

Key Findings Of The Study 

• Depending on product & service, the protective barriers segment held largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• On the basis of infection type, the urinary tract infections segment garnered the largest share in 2020, and is expected to continue this trend during the forecast period
• By end user, the hospitals & clinics segment led the market in 2020, and is anticipated to dominate throughout the forecast period.  
• Region wise, Asia-Pacific is expected to register a CAGR of 5.4% during the forecast period. 

In 2020, North America accounted for the major share in the hospital-acquired infection control market, owing to rise in adoption of sterilization & disinfection products along with contract sterilization services, increase in need for hospital-acquired infection control to minimize the prevalence, and surge in geriatric population. However, Asia-Pacific is projected to register the fastest growth during the forecast period, owing to increase in awareness related to personal hygiene, rise in number of surgical procedures, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system.